PolyPid's D-PLEX₁₀₀ Wins BioTech Breakthrough Award for "Therapeutics Solution of the Year"

PETACH TIKVA, Israel, Nov. 06, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company focused on improving surgical outcomes, today announced that D-PLEX₁₀₀, the company’s lead candidate, has been named "Therapeutics Solution of the Year" by BioTech Breakthrough, a leading independent market intelligence organization which evaluates and recognizes standout life sciences and biotechnology companies, products and services around the globe.

Read more at globenewswire.com